Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 13/20 | 0.88 |
| ▸ | FAAH | O00519 | 2/20 | 0.70 |
| ▸ | GHSR | Q92847 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | KIT | P10721 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30218755 | 0.93 | MGLL (1.00) | MGLLFAAHGHSRPTGDR2 | |
| SCHEMBL20567077 | 0.93 | MGLL (1.00) | MGLLFAAHGHSRPTGDR2 | |
| SCHEMBL24235957 | 0.93 | MGLL (1.00) | MGLLFAAHGHSRPTGDR2 | |
| SCHEMBL20567073 | 0.93 | MGLL (1.00) | MGLLFAAHGHSRPTGDR2 | |
| SCHEMBL25829969 | 0.89 | MGLL (0.88) | MGLLFAAHPTGDR2 | |
| SCHEMBL25830235 | 0.89 | MGLL (0.88) | MGLLFAAHPTGDR2 | |
| SCHEMBL25830232 | 0.89 | MGLL (0.88) | MGLLFAAHPTGDR2 | |
| SCHEMBL20567694 | 0.83 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL20567185 | 0.83 | MGLL (1.00) | MGLLFAAH | |
| SCHEMBL30420692 | 0.83 | MGLL (1.00) | MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | MGLL 1/4885FAAH 33/4885GHSR 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.